Emerging Markets: What Changed – Friday, April 20
Apr 20, 2018
Jeremy Parkinson
Finance
(from my colleague Dr. Win Thin) The Reserve Bank of India is tilting more hawkish. Tensions on the Korean peninsula are easing. The Trump administration reversed course on Russia sanctions. Turkey is heading for early elections. Raul Castro stepped down as president of Cuba. Mexico polls show continued gains for Andres Manuel Lopez Obrador. In […]
26 Firms Going Ex-Dividend Next Week, Including Clorox, Lowe’s And Morgan Stanley
Apr 20, 2018
Jeremy Parkinson
Finance
Ex-dividend dates are important to dividend investors because one must own a stock on its ex-dividend date in order to be eligible to receive its next dividend. Any stock ranked by our team as a Top 100 Dividend Stock is tagged. Company Name Stock Symbol Ex-Div Date Pay Date Div Payout Stock Price Yield Market Value CNH Industrial […]
All Signs Are Pointing To A Market Collapse Far Worse Than 2008
Apr 20, 2018
Jeremy Parkinson
Finance
Here are the articles used in today’s discussion: The Fed Has Forgotten the Lessons of 2008, but Big Banks Haven’t Margin, Leverage, Subprime Loans: All at Worse-Than-2008-Crisis Levels
Don’t Rule Out A Run In The USD
Apr 20, 2018
Jeremy Parkinson
Finance
(Audio length 00:12:42) With markets down across the board the only decent green I am seeing on my screen is the USD. Chris Temple and I briefly discussed the dollar yesterday but spend more time focusing on it today. We look at the technical levels to watch as well as how the central bank actions […]
Is The Dollar Offering Its Final Warning?
Apr 20, 2018
Jeremy Parkinson
Finance
Imagine for a moment the hypothetical situation where the reign of King Dollar as we know it has come to an end. In that scenario, what are some of the signs you might expect to see right before the final collapse occurred? Would one of the tell-tale signs be to see the U.S. debt load […]
Sage Therapeutics Slumps As Biogen Deal May Dampen M&A Hopes
Apr 20, 2018
Jeremy Parkinson
Finance
Weakness in shares of Sage Therapeutics (SAGE) may be related to news that Biogen (BIIB) and Ionis Pharmaceuticals (IONS) have expanded their strategic collaboration through a new ten-year collaboration agreement, which may be read by some market participants as lowering the odds for M&A action related to Sage. Under the terms of the collaboration, Biogen […]
EUR/USD – Headed Below 1.22?
Apr 20, 2018
Jeremy Parkinson
Finance
Euro is trading lower ahead of next week’s European Central Bank’s monetary policy announcement. After consolidating for 8 trading days and failing to break above 1.24 throughout that time, the EUR/USD finally broke down on cautious comments from ECB member Weidmann. The head of Germany’s Bundesbank said there were recent indications that the first […]
3 Mutual Funds To Buy On Phenomenal Housing Data
Apr 20, 2018
Jeremy Parkinson
Finance
Per the latest joint report from the U.S. Census Bureau and the U.S. Department of Housing and Urban Development, housing starts and building permits for March came in at 1.32 million and 1.35 million units, respectively. While housing starts increased 1.9% in March, building permits advanced about 2.5% in the same period. The metrics followed […]
ACM Research Shares Could Fall When IPO Lockup Expires
Apr 20, 2018
Jeremy Parkinson
Finance
The 180-day lockup period for ACM Research, Inc. (NASDAQ:ACMR) ends on May 2, 2018. When this six-month period ends, the company’s pre-IPO shareholders will have the opportunity to sell large blocks of previously restricted shares. We believe that they are likely eager to do so – ACMR has a return from IPO of more than 110%. […]
What’s Bitcoin Really Worth?
Apr 20, 2018
Jeremy Parkinson
Finance
What’s Bitcoin really worth? This question might really drive you mad if you think hard enough about it. $0? $10? Maybe $1,000,000 for one coin? The range of the numbers can make your head spin but it is the explanation behind the number that matters. For the most part, investors don’t have a good reason […]